During the past decade, Sisu BHR, LLC conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sisu BHR, LLC" are "Attention Deficit/Hyperactivity Disorder" (1 trials) and "Post-Traumatic Stress Disorder" (1 trials). Many other conditions were trialed in "Sisu BHR, LLC" in a lesser frequency.

Most popular intervention types in "Sisu BHR, LLC" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Adhansia XR" (1 trials), "BI 1358894" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sisu BHR, LLC" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sisu BHR, LLC". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Sisu BHR, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sisu BHR, LLC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".